Founder and CEO of Spiral Therapeutics, a US-based pharmaceutical company delivering therapies for hearing loss and balance disorders, Hugo Peris has spent over 15 years building and scaling healthcare ventures across Europe, Asia and North America. Between 2010 and early 2018, Hugo was an executive and served on the Board of Luqa Pharmaceuticals, a China-based and China-focused specialty pharmaceutical company, later acquired by China Medical System (CMS (0867.HK)).
He is an active angel investor in digital health, medtech, and biotech. Hugo earned a graduate degree in International Business and a Master's degree in Health Economics and Pharmacoeconomics from Universitat Pompeu Fabra in Barcelona.
PORTFOLIO
- Contraline
- Nacuity
- Artha Health
- Aortyx
- Jazz Surgical
- Stimable
- Stimusil
- XPND (MouthX)
- Weigh Boat Dispenser
- Oto Health
- Fitbod
